newsfilter
← Latest News
ACCESS Newswire·

Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue

ESTERO, FL / ACCESS Newswire / April 16, 2026 / Aspire Biopharma Holdings, Inc. , a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology,